SEC Form 4 · accession 0001225208-17-015551
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rochelle B Lazarus
Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 2, 2017 · 3:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 4,594 | D | ||
| Common Stock | holding | — | — | — | 1,757 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF3,F1,F2 | — | Sep 29, 2017 | A | 429 | A | — | — | Common Stock | 429 | 72,326 | D |
Explanation of responses
- F11-for-1
- F2Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
- F3Holdings include shares acquired in dividend reinvestment transactions.